Small Cap Gainers: KPTI, CMBM, AMPL
3:07 pm Friday, February 18th, 2022
Karyopharm Therapeutics Inc (NASDAQ:KPTI): Rallies to its highest levels in close to a year on above 4x average volume, now up approx. +59% month-to-date. Strength in the name today has been attributed to reports suggesting that co has cancelled out of a conference. Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases.
Cambium Networks Corp (NASDAQ:CMBM): Reported upside results for Q4, reflecting continued strong demand for co’s products. Issued a mixed Q1 outlook while guiding FY22 EPS and revs above estimates. Co expects supply chain issues to “substantially improve” through the latter half of calendar year 2022. Cambium Networks Corporation, through its subsidiaries, provides wireless broadband networking infrastructure products and solutions for network operators.
Amplitude Inc (NASDAQ:AMPL): Continued volatility following co’s release of Q4 earnings results earlier this week. The stock rebounds after reaching new record lows early in the session. Amplitude, Inc. provides a digital optimization system to analyze customer behavior within digital products.
